Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05528939 · ClinicalTrials.gov registry record · NA
Feasibility/Acceptability of Attentional-Control Training in Survivors
A NA study of Pediatric Cancer and Pediatric ALL, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05528939: Recruiting NA study of Pediatric Cancer and Pediatric ALL, sponsored by Children's National Research Institute.
NCT05528939 is a NA study of Pediatric Cancer and Pediatric ALL that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 50 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05528939, a NA study of Pediatric Cancer and Pediatric ALL, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
Primary Outcome
Feasibility will be determined by examining the proportion of eligible patients/families approached about the study who enroll
Conditions Studied
Interventions
- DEVICE EndeavorRx
- OTHER Control video game
Study Locations (1)
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT05528939 shows while recruiting
NCT05528939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which EndeavorRx is the first listed.
NCT05528939 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05528939 about?
NCT05528939 is a clinical study titled "Feasibility/Acceptability of Attentional-Control Training in Survivors". This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
What is the current status of trial NCT05528939?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-06-14. Estimated completion is 2025-08-31.
What conditions does trial NCT05528939 study?
This clinical trial studies the following conditions: Pediatric Cancer, Pediatric ALL, Pediatric Brain Tumor, Attention Difficulties, Cognitive Deficit in Attention.
What interventions are being tested in trial NCT05528939?
The interventions under investigation include: EndeavorRx (DEVICE), Control video game (OTHER).
Who is sponsoring clinical trial NCT05528939?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05528939 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05528939's enrollment target sits among peer trials
50 29th of 51 higher than 22 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI